Science
Mechanism of Action
SH-Oligopeptide-1, known interchangeably as Epidermal Growth Factor (EGF), acts as a critical cell-communicating agent. It actively binds to the epidermal growth factor receptor (EGFR), a pathway essential for stimulating cell survival, differentiation, and proliferation, thereby accelerating skin's natural repair mechanisms and overall regeneration. This process boosts the synthesis of vital extracellular matrix components, including structural proteins like collagen and elastin, contributing to enhanced skin barrier function, reduced inflammatory responses, scar reduction, and sustained moisturization. Furthermore, it encourages the proliferation of keratinocytes, endothelial cells, and fibroblasts. SR-Jellyfish Polypeptide-1 complements this action by serving as an antioxidant and skin-protecting agent. Collectively, these peptides signal the body to initiate skin's intrinsic repair and regenerative processes, visibly contributing to wrinkle reduction.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Key findings
- 01 While the scientific basis and preclinical bioactivity of direct clinical studies on SH-Oligopeptide-1 have been subject to scrutiny, this component is sanctioned for generalized cosmetic use across various concentrations. Insights from similar growth factors, specifically barley bioengineered epidermal growth factor, indicate statistically significant improvements in the appearance of fine lines, rhytids, skin texture, pore size, and dyschromatic conditions within the initial month of use, with benefits progressively enhancing over three months. Direct efficacy data for the SR-Jellyfish Polypeptide-1 component within this complex is not explicitly detailed.
Transparency
Dusting Analysis
Current research does not provide information regarding the potential for dusting with this ingredient.
The Formula
Formulation
Stability
Bioactive Epidermal Growth Factor (EGF), a key component, exhibits relatively prolonged stability within formulated products.
Safety
Safety Profile
The full ingredient complex, SR-JELLYFISH POLYPEPTIDE-1 SH-OLIGOPEPTIDE-1, has not undergone direct safety assessments by regulatory bodies such as CIR, SCCS, or FDA. Although SH-Oligopeptide-1 is approved for cosmetic use at several concentrations, its long-term risks remain unspecified. Concerns exist that EGF's mitogenic (cell-proliferating) nature could theoretically facilitate the spread of pre-existing cancerous cells; however, it is generally not considered carcinogenic in individuals without cancer. While typically non-irritating, there is a possibility of irritation, which may intensify when formulated with other problematic ingredients.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While this ingredient demonstrates a promising mechanism for skin regeneration and protection, robust, direct clinical data for the full complex and comprehensive long-term safety profiles for its key component are not yet firmly established, warranting further research for a conclusive assessment.
Related
Similar Ingredients
Finding similar ingredients…